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A previously well 22-year-old woman presented with progressive 
weakness of her legs and urinary incontinence over 7 days. Clinically 
she was healthy, with no skin rashes. On neurological examination 
she had profound bilateral weakness of the lower limbs, hypertonia, 
hyperreflexia, a positive Babinski sign and a T6 sensory level. Tests 
for syphilis and HIV and screening for auto-immune conditions were 
negative.  
Magnetic resonance imaging (MRI) of the brain and spinal 
cord revealed extensive cord swelling between the craniocervical 
junction and T11 (Fig. 1), a high signal in the right optic nerve 
and a normal brain. Aquaporin 4 antibodies (neuromyelitis optica 
immunoglobulin G (NMO-IgG)) were positive with a titre of 1:1 000. 
These findings confirmed a diagnosis of NMO or Devic’s disease.
Discussion 
NMO is a chronic, inflammatory, demyelinating disease of the 
central nervous system characterised by severe attacks of optic 
neuritis and myelitis that spare the brain in the early stages.[1] 
Women are more commonly affected, accounting for 85% of 
cases.[2] Sequential or simultaneous optic neuritis and transverse 
myelitis are typical features. Optic neuritis and myelitis may occur 
separately during several months or years, but more than half of 
patients experience optic nerve or spinal cord relapse within one 
year after the initial clinical event. Optic neuritis usually presents 
with unilateral or, less often, bilateral ocular pain and vision loss. 
Myelitis caused by NMO often presents as complete transverse 
myelitis with tetraplegia or paraplegia, a well-defined sensory level 
and sphincter dysfunction. Brainstem involvement may cause 
intractable hiccups and vomiting.[1]
Spinal cord lesions extending over three or more vertebral segments 
is the most reliable MRI finding for the diagnosis of NMO. Brain MRI 
is initially normal in most patients. Cerebrospinal fluid analysis may 
reveal a pleocytosis of >50 white blood cells/mm3. 
The detection of NMO-IgG is more than 75% sensitive and 95% 
specific for NMO.[3]
Intravenous high-dose corticosteroid therapy is commonly the 
initial treatment for acute attacks. Tapering for a period of 2 - 6 
months is advised to prevent exacerbations. Rescue therapy with 
plasma exchange may benefit patients who do not respond to 
corticosteroid therapy. Maintenance immunosuppressive therapy 
is a generally accepted strategy for reducing relapses. Azathioprine 
in combination with oral prednisone reduces the frequency of 
attacks.[1]
NMO causes devastating neurological deficits and may cause 
blindness. A high index of suspicion is needed in patients who 
present with transverse myelitis and optic neuritis. 
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Fig. 1. Sagittal T2 weighted MRI of the spine. Extensive cord swelling and 
cord signal abnormality (arrows) between the cranial cervical junction and 
T11 are visible.
